In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Houston is now in position to come back from a 3-1 series deficit for the third time in franchise history. "He's amazing," center Alperen Sengun said. "We've been saying that for two years now.

The tech-heavy Nasdaq led the rally among all major indices, finishing up by 1.51 percent ... our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for ...

DexCom, Inc. DXCM reported first-quarter 2025 adjusted earnings per share (EPS) of 32 cents, which missed the Zacks Consensus Estimate of 33 cents by 3 ... G7 System, which features improved ...

Qubo Dashcam Pro 3K with Sony STARVIS 2 sensor is priced at Rs 10,990 –Qubo ... Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech ...

Dexcom reaffirmed its 2025 revenue guidance ... impacted by expedited freight costs and supply chain adjustments following sensor shipment damages last year. Adjusted EBITDA for Q1 was $230.4 ...

Investing.com -- DexCom ... jump 3.9% after the continuous glucose monitoring (CGM) device maker reported first-quarter revenue that surpassed analyst estimates, despite a slight miss on earnings per ...

The company posted an EPS of $0.32, just below the forecasted $0.33, while revenue reached $1.04 billion, surpassing the expected $1.02 billion. Following the earnings release, DexCom’s stock rose 3.2 ...

DexCom (DXCM) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago. These figures ...

Nine analysts surveyed by Zacks expected $1.02 billion. DexCom expects full-year revenue of $4.6 billion.